Pharmaron Beijing Co Ltd (300759) — Cash Flow-to-Debt Ratio
Pharmaron Beijing Co Ltd (300759) has a Cash Flow-to-Debt Ratio of 0.10x as of September 2025, meaning its operating cash flow of CN¥1.04 Billion could theoretically repay 0% of its total liabilities (CN¥10.62 Billion) in one year. See 300759 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Pharmaron Beijing Co Ltd Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for Pharmaron Beijing Co Ltd across 11 annual periods. Also explore Pharmaron Beijing Co Ltd (300759) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Pharmaron Beijing Co Ltd (2014–2024)
Year-by-year debt coverage analysis for Pharmaron Beijing Co Ltd. For market capitalisation and broader financial context, see 300759 market cap.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.27x | CN¥2.58 Billion | CN¥9.70 Billion | ▲ +27.7% |
| 2023 | 0.21x | CN¥2.75 Billion | CN¥13.24 Billion | ▼ -6.3% |
| 2022 | 0.22x | CN¥2.14 Billion | CN¥9.65 Billion | ▼ -12.7% |
| 2021 | 0.25x | CN¥2.06 Billion | CN¥8.09 Billion | ▼ -54.1% |
| 2020 | 0.55x | CN¥1.65 Billion | CN¥2.98 Billion | ▲ +23.8% |
| 2019 | 0.45x | CN¥938.59 Million | CN¥2.10 Billion | ▲ +38.6% |
| 2018 | 0.32x | CN¥737.26 Million | CN¥2.28 Billion | ▲ +11.6% |
| 2017 | 0.29x | CN¥552.22 Million | CN¥1.91 Billion | ▲ +27.7% |
| 2016 | 0.23x | CN¥235.77 Million | CN¥1.04 Billion | ▲ +5.0% |
| 2015 | 0.22x | CN¥216.94 Million | CN¥1.01 Billion | ▲ +1096.2% |
| 2014 | 0.02x | CN¥12.13 Million | CN¥673.22 Million | — |